WASHINGTON, Dec 26 (Reuters) - U.S. biotechnology firm XOMA Ltd (XOMA.O: Quote, Profile, Research) filed with regulators on Wednesday to periodically sell up to $150 million in common and preference shares, debt securities and warrants.
WASHINGTON, Dec 26 (Reuters) - U.S. biotechnology firm XOMA Ltd (XOMA.O: Quote, Profile, Research) filed with regulators on Wednesday to periodically sell up to $150 million in common and preference shares, debt securities and warrants.
